Examkin

Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A 58-year-old female is admitted to the cardiac telemetry unit for the elective initiation of an antiarrhythmic medication. She has a history of highly symptomatic paroxysmal atrial fibrillation that has been refractory to maximum tolerated doses of metoprolol and flecainide. The patient currently feels well and denies chest pain, palpitations, or shortness of breath. Her home medications include metoprolol succinate, apixaban, and atorvastatin. Her vital signs are within normal limits. The attending physician plans to initiate dofetilide to maintain sinus rhythm.

Which of the following monitoring parameters and laboratory studies are MANDATORY to obtain prior to the first dose and at designated intervals during the initial 72 hours of this therapy? (Select 3 answers)

  1. Serial 12-lead electrocardiogramsCevap
  2. Calculated creatinine clearanceCevap
  3. Serum potassium and magnesium levelsCevap
  4. D
    Hepatic aminotransferases (AST/ALT)
  5. E
    Prothrombin time and international normalized ratio (PT/INR)
  6. F
    Serial high-sensitivity cardiac troponin levels

Cevap

The mandatory parameters for dofetilide initiation are serial 12-lead electrocardiograms, calculated creatinine clearance, and serum potassium and magnesium levels.
Dofetilide is a Class III antiarrhythmic that significantly prolongs the QTc interval, carrying a high risk of Torsades de Pointes. Because of this fatal proarrhythmic potential, clinical guidelines mandate an inpatient initiation protocol lasting a minimum of 72 hours72 \text{ hours} (or 5 doses). During this period, continuous telemetry and serial 12-lead ECGs are required to strictly track QTc changes. Additionally, because the drug is primarily cleared by the kidneys via active tubular secretion, creatinine clearance must be calculated to determine the safe starting dose, as drug accumulation drastically increases toxicity. Furthermore, hypokalemia and hypomagnesemia increase the resting membrane potential instability, facilitating early afterdepolarizations and arrhythmias; thus, serum potassium and magnesium must be verified and strictly maintained (typically potassium >4.0 mEq/L> 4.0 \text{ mEq/L} and magnesium >2.0 mg/dL> 2.0 \text{ mg/dL}).

Adım Adım Çözüm

1
Identify the high-risk pharmacotherapy being initiated.
The patient is starting dofetilide, a Class III antiarrhythmic agent.
Recognizing the specific medication allows for retrieval of its distinct adverse effect profile and FDA-mandated safety protocols.
2
Determine the primary toxicity and clearance mechanisms of dofetilide.
Dofetilide causes dose-dependent QTc prolongation and is primarily cleared by the kidneys.
Understanding the pharmacokinetics and pharmacodynamics guides the selection of necessary lab and diagnostic monitoring.
3
Select the guideline-mandated monitoring parameters.
Serial ECGs (for QTc monitoring), calculated creatinine clearance (for renal dosing), and electrolytes (potassium and magnesium) are selected.
These specific parameters directly mitigate the risk of life-threatening Torsades de Pointes.

Anahtar Kavram

Dofetilide must be initiated in an inpatient setting for at least 72 hours (or 5 doses) with continuous ECG monitoring, calculation of creatinine clearance for dose adjustment, and strict maintenance of serum potassium and magnesium levels to minimize the risk of Torsades de Pointes.
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru